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Abstract
Introduction: Some clinical trials revealed a correlation between increased serum estrogen 
and nasal symptoms or inflammatory changes in nasal mucosa. Estrogen receptors tend to be 
controlled by a negative feedback, to avoid a deleterious stimulus over several body functions 
while in hyperestrogenic periods. This study proposes a hypothesis where mechanisms regulat-
ing expression of estradiol receptors in nasal mucosa are absent in some patients, and their 
concentration remains steady even in periods of high serum hormonal concentration, potential-
ly leading to local estrogenic symptoms in nasal mucosa. 
Study design: This was an experimental prospective study. 
Aim: To determine whether estrogen levels induce the reduction of the number of estrogen 
receptors in the nasal mucosa. 
Methods: In the present study, 30 adult male guinea pigs were subjected to a biopsy of the 
middle nasal turbinate and received 0.5 mL of estradiol cypionate intraperitoneally for 30 
consecutive days. Afterwards, samples from contralateral middle turbinate were obtained. Im-
munohistochemical analysis of estrogen receptors were performed pre- and post-treatment. 
Results: The post-treatment group showed reduction of receptor expression when compared to 
the pre-treatment group. (p = 5.2726-5). 
Conclusion: A reduction in the expression of the nasal estrogen receptor was observed after 30 
days of estradiol administration.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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A influência da administração de estradiol nos receptores de estrógeno da mucosa nasal: 
estudo experimental em cobaias 
Resumo
Introdução: A literatura indica uma correlação entre estrogênio elevado no soro e sintomas 
nasais ou alterações inflamatórias na mucosa nasal. Os receptores de estrogênio tendem 
a ser controlados por retroalimentação negativa, para evitar um estímulo nocivo sobre as 
diversas funções corporais em períodos de hiperestrogenismo. Propomos uma hipótese em 
que os mecanismos que regulam a expressão de receptores de estradiol na mucosa nasal 
estão ausentes em alguns pacientes, e a sua concentração permanece estável mesmo em 
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Introduction
Rhinitis may be classified into two groups: allergic and 
non-allergic. The non-allergic group includes hormonal rhi-
nitis, in which inflammatory alterations in nasal mucosa are 
associated to elevated hormone levels, such as hyperestro-
gen states occurring during pregnancy, menstruation, or 
with use of hormonal contraception.1-3
Hormonal rhinitis has been the focus of clinical trials 
since the 19th century, when several authors published 
studies correlating hormonal fluctuations with nasal symp-
toms. Many authors4-7 carried out experimental studies 
disclosing histological and histochemical changes in nasal 
mucosa in response to changes in the concentration of se-
rum estrogen.
Some clinical trials8-16 observed a correlation between 
increased serum estrogen and nasal symptoms or inflamma-
tory changes in nasal mucosa on clinical and laboratory ex-
ams. Conversely, other studies, such as those by Mabry,17 by 
Ellegard,18,19 by Bende and Gredmark,20 and by Salaroli et 
al.21, failed to confirm this correlation.
Toppozada et al.22-24 observed histological and histochem-
ical alterations in the human nasal mucosa of women who 
were pregnant or using contraceptive pills, compared with a 
control group. Caruso et al.12 and Nappi et al.25 noticed that 
the vaginal and nasal respiratory epithelium exhibited the 
same histologic aspects in the respective phases of the men-
strual cycle and during menopause.
The first estrogen receptor (ER) to be described, alpha 
(ERα), was isolated by Elwood Jensen in 1958. In 1996, En-
mark and Gustafsson26 discovered a second type of recep-
tor, beta (ERβ). Theories proposed about the physiological 
functions of these two isoforms implicate selective action of 
estrogen in different tissues.
Thus, research into the two receptors subtypes has 
been conducted in a range of different organs and tissues. 
ERβ was found in the prostate, ovaries, testicles, uterus, 
hypophysis, bladder, lungs, salivary glands, oral mucosa, 
thymus, adrenals, olfactory tract, central nervous system, 
heart, kidneys, and in cells of the immunologic system.27 
ERα was found at highest concentrations in the uterus, vagi-
na, and breasts;28 however, few studies investigating ERs in 
nasal mucosa are available.
The mucosa of lower nasal turbinates in women with 
chronic rhinopathy was investigated by immunohistochem-
istry for ERs,  which were dectected in the cytoplasm of 
glandular epithelium cells.29,30 Millas31 employed immuno-
histochemistry to study estrogen ERα and ERβ in the mucosa 
of lower nasal turbinates of normal subjects. All 11 cases 
studied (five women and six men) presented ERα and ERβ 
(predominantly the latter) in the cytoplasm of glandular ep-
ithelial cells of the lamina propria. When studying individu-
als with chronic rhinopathy, Shirasaki et al.32 observed ERα 
in the nuclei of mastocytes, and ERβ in nuclei of cells of the 
glandular epithelium of the lamina propria.
Controversy remains over the site and function of re-
ceptors for estrogen in nasal mucosa. Millas et al.33 as-
sessed the influence of oral contraceptives on the distribu-
tion and density of ERs in the nasal mucosa of women, and 
observed that those using contraceptive pills had a lower 
number of receptors in the lamina propria.
The expression of receptors in cells is dynamic and regulated 
mainly by the concentration of their cognate ligands. Reports by 
Jensen and Gorski describing the regulation of ER concentration 
observed that estrogen treatment led to a decrease in cytosolic 
ERs, based on the reduction in specific binding to 17β-estradiol. 
Given that the receptors are the key determinants of the action 
of several hormones in target cells, and that evidence points to 
a possible estrogen activity in nasal mucosa, the mechanism of 
down-regulation may explain the fact that, in general, women 
do not present significant nasal effects when there is marked 
variation in their sexual hormones.
Inversely, a hypothesis may be proposed that mecha-
nisms regulating receptors expression are absent and that 
their concentration remains steady even during high hor-
monal concentration, potentially leading to local estrogenic 
symptoms in nasal mucosa. This study aimed to determine 
whether an elevation in circulating estrogen levels influenc-
es the concentration of ERs in guinea pig nasal mucosa.
Materials and methods
A prospective study of nasal mucosa samples from 30 adult 
male guinea pigs weighting between 300 g and 400 g was 
performed.
períodos de elevada concentração sérica hormonal, o que pode conduzir a sintomas locais 
na mucosa nasal.
Desenho do estudo: estudo prospectivo experimental. 
Objetivo: Determinar se altos níveis de estrogênio induzem à redução no número de recepto-
res de estrogênio na mucosa nasal.
Material e método: Trinta cobaias foram submetidas à biópsia da concha nasal, recebendo 
0,5 ml de cipionato de estradiol por via intraperitoneal por trinta dias consecutivos. Em se-
guida foram obtidas amostras da concha nasal contralateral. As análises imuno-histoquímicas 
dos receptores de estrógeno foram realizadas antes e depois da hormonioterapia.
Resultados: O grupo pós-tratamento mostrou uma redução da expressão dos receptores 
(p = 5,2726-5). 
Conclusão: Redução na expressão do receptor de estrogênio nasal foi encontrada após trinta 
dias de administração de estradiol.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
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The procedures were conducted in accordance with the 
regulations of the research ethics committee of the Unit 
for Experimental Surgery Technique and complied with Bra-
zilian Federal Law No. 1153/95 as well as with the ethical 
principles for animal experiments established by the Brazil-
ian College of Animal Experimentation (Colégio Brasileiro de 
Experimentação Animal - COBEA).
Procedures
The surgical procedures were performed under anesthesia 
with tiletamine chlorohydrate 125 mg/5 mL and zolazepam 
chlorohydrate 125 mg/5 mL, at a dose of 0.4 mL/kg, in ad-
dition to fentanyl citrate + droperidol. Guinea pigs were 
submitted to a biopsy of left nasal mucosa material using 
a punch biopsy forceps, obtaining fragments measuring ap-
proximately 2 × 2 × 2 mm. All fragments were immersed 
immediately upon collection in 4% buffered formalin and 
sent for histologic processing.
Guinea pigs were given 0.5mL of estradiol cypionate, 
sterile solution, 2mg/mL (E.C.P.TM, Pfizer) intraperitoneally, 
daily for 30 days. The guinea pigs were given access to feed 
and water ad libitum. After 30 days of hormonal therapy, 
the guinea pigs were sacrificed by injection of a lethal dose 
of potassium chloride under anesthesia, and submitted to 
exposure and removal of the nasal mucosa of the middle 
turbinate contralateral to the initial biopsy site.
Immunohistochemical analysis
The tissue samples underwent sequential immersion in 
buffered formalin for 1h, immersion in absolute alcohol 
(six times in different recipients, each for 1h), immer-
sion in xylol (four times in different recipients, each for 
1h), and immersion in liquid paraffin (twice in differ-
ent recipients, each for 1 h). Subsequently, specimens 
were embedded in liquid paraffin. The paraffin blocks for 
the two time points were sent to the Rodent Histopathol-
ogy Core of the Pathology Department of Harvard Medi-
cal School, Boston, United States, where blocks were cut 
into 4µm-thick slices and mounted on electrically charged 
slides, with each slide holding two slices. The slides were 
then sent to the pathology laboratory of the Brigham and 
Women’s Hospital, Boston, United States, for immunohis-
tochemical processing. In this procedure, the slides were 
submitted to the deparaffination process by immersion 
for 10 minutes in Hemo-DeTM (Scientific Safety Solvents 
- Texas, USA), followed by immersion in six different 
recipients of absolute alcohol. Endogenous peroxidase 
blocking was then performed by immersion in a solution 
constituting 30% volume of 3% hydrogen peroxide and 70% 
volume of absolute alcohol. The slides were then washed 
in running water for 3 minutes.
Antigenic recovery was then performed by immer-
sion in buffered pH 6-citrate solution pre-heated to 25°C 
for 30 minutes. The sections were delimited using a pap 
penTM (SciTek Laboratories). Slides were left for 1 minute 
in a recipient containing 500ml of PBS with 10 mL of 1% 
BRU. After removal from this solution, the non-specific 
primary anti-body H222 was applied (marker of both ERα 
and ERβ) for ERs at a final concentration of 5µg/mL, and 
submitted to overnight incubation at 4°C in a wet cham-
ber. Following incubation, slices were rinsed with PBS to 
remove excess primary antibody and then re-immersed 
in PBS/BRU 1% solution for 10 minutes. Slices were in-
cubated with the secondary antibody Mouse Envision+TM 
(DakoCytomation - Glostrup, Denmark) for 30 minutes, 
rinsed again with PBS, and immersed in a PBS/BRU 1% 
solution for 10 minutes. Sections were then incubated in 
a solution of DAB+TM (DakoCytomation), 1 drop per mL 
of buffer for 10 minutes. Upon removal from incubation, 
slides were rinsed in running water, counterstained with 
Mayer’s hematoxylin (1.5 minutes), rinsed again, submit-
ted to Scott’s water (1 minute), and again washed in run-
ning water. Sections were then dehydrated, dried, and 
mounted with coverslips.
Slides were analyzed pairwise, comparing the images 
obtained before and after hormone therapy through relative 
optical density (RODTM) analysis.
ROD is a software for quantitative imaging assessment 
that estimates the quantity of solid aggregates in a single 
bi-dimensional image, after due calibration for a known 
vertical thickness (immunohistochemistry slide) (Fig.1). The 
methodology reduces the subjectivity of the observations 
and enables numerical determination of the tissue stained, 
facilitating comparison between pairs. For each specimen, 
four separate pre- and post-therapy slides were assessed, 
and the average result was used.
Results
Results were compared using the parametric Student’s 
t-test for paired samples (pre- and post-hormone therapy).
The results of the paired group analysis are shown in 
Table 1.
Animals 16 and 19 presented no glands in their respec-
tive histological slices, whereas the post-therapy slides for 
animal 23 were lost.
Figure 1 Immunohistochemical study for estrogen receptors befo-
re (A) and after (B) hormone therapy (40×).
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Table 1 Optical density of slides before and after estradiol treatment.
Pre-treatment Post-treatment
Animals ROD Animals ROD
1 0.146625 1 0.12415
2 0.109225 2 0.133775
3 0.102725 3 0.098925
4 0.176725 4 0.09625
5 0.144075 5 0.114875
6 0.14935 6 0.119275
7 0.1679 7 0.132025
8 0.1308 8 0.10255
9 0.137575 9 0.126675
10 0.1528 10 0.0935
11 0.17205 11 0.11185
12 0.146625 12 0.12415
13 0.109225 13 0.133775
14 0.102725 14 0.098925
15 0.176725 15 0.09625
17 0.144075 17 0.114875
18 0.14935 18 0.119275
20 0.1679 20 0.132025
21 0.1308 21 0.10255
22 0.137575 22 0.126675
24 0.1528 24 0.0935
25 0.17205 25 0.11185
Statistical analysis
The parametric Student’s t-test was performed us-
ing the ROD’s results of samples from 19 animals from 
pre- and post-therapy slides. The groups were statistical-
ly different; the pre-treatment group presented a high-
er number of receptors than the post-treatment group 
(p = 0.000005726)
Discussion
Based on clinical observations, a number of studies indicate 
a correlation between hormonal changes and nasal obstruc-
tion. Hormonal rhinitis is cited in various otorhinolaryngolo-
gy textbooks, yet its underlying physiopathological mecha-
nism remains unclear.
Many studies have already indicated the activity of femi-
nine sexual hormones over the nasal mucosa. It is postulated 
that, in situations of increased serum hormone (estrogen) 
levels, there is a stimulus for increased expression of its re-
ceptors,34 triggering changes in the density and localization 
of these receptors.
In the present study, the influence of estradiol admin-
istration on the expression of ERs in the nasal mucosa of 
guinea pigs was observed.
Some issues were observed during the course of the 
present study, including excessive tissue fragmentation in 
the pre-estrogen treatment group, which was most likely 
due to the tissue collection technique employed. The spec-
imens were taken with a small punch biopsy forceps intro-
duced into the nasal cavity. Consequently, the exact site of 
tissue collection was not precise; besides, the mechanism 
of action of the instrument (gripping and pulling) may also 
have led to excessive tissue laceration, evidenced on the 
22 Costa HO et al.
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slides by a lack of continuity and quality. Additionally, this 
technique allowed for the collection of only small volumes 
of material, reducing the quality of histological slices. Con-
versely, the post-estrogen treatment group had histological 
slices with higher quality, since the tissue samples were ob-
tained after full surgical exposure of the nasal cavity, en-
abling the collection of larger amounts of tissue through 
slicing with a sharp blade. Nevertheless, the fragmentation 
of the tissue did not compromise the representation of 
glands on the pre-treatment slides, which showed a good 
level of immunohistochemical staining.
The suitability of the immunohistochemical staining may 
also be called into question because the lack of primary 
antibody activity (H222, non-specific antibody for specific 
estrogenic receptors for guinea pig species) precluded the 
assessment of antibody activity, since it was not possible 
to obtain positive and negative control slides. It is worth 
remembering that the H222 antibody, specific for the guinea 
pig species, and which provides non-specific staining of ERs, 
is no longer commercially available. Geoffrey Greene, who 
developed the H222 antibody in association with the compa-
ny Abbott, offered the material used in this study.
The significant reduction of ERs found in animals 
post-treatment suggests the existence of a negative feed-
back mechanism triggered by excessive plasma hormone 
levels. This relationship is poorly discussed in the literature 
to the degree that the cases of hormonal modification relat-
ed to nasal reactivity take place during hormonal instability 
such as pre-menstrual, pregnancy, and menopausal periods.
The expression and stability of the ER is the result of 
a complex process modulated by estrogens and anti-estro-
gens. This regulation appears to be the result of two dif-
ferent regulatory mechanisms. Firstly, exposure to estrogen 
triggers a rapid fall in the mRNA levels and in the proteins 
responsible for producing ERs. Secondly, exposure to estro-
gen leads to an increase in the steady state level of mRNA.35
These mechanisms may be absent in women with symp-
toms of hormonal rhinitis, resulting in the persistence of the 
receptor level even in the presence of excessive estrogen.
An approach to ascertain the impact of excess estrogen 
could be to assess the impact of hormone replacement in 
the ER concentration of the nasal mucosa of post-meno-
pausal women.
Conversely, the negative relationship between estrogen 
use and the number of nasal ERs indicates a potential util-
ity of topical treatment for the management of rhinitis 
with a significant glandular component, rhinorrhea, and 
nasal edema.
Conclusion
A significant reduction in the expression of ERs was observed 
in the nasal mucosa of animals who received estradiol for 
30 days.
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